Everything you need to know about AI-Guided TMS Targeting: How Machine Learning Is Making Brain Stimulation More Precise — how it works, what it costs, and how to find a provider who actually knows what they're doing.

TMS therapy has helped hundreds of thousands of people with treatment-resistant depression. But here is something most people do not hear during their consultation: the standard method for aiming the magnetic coil has not changed much since the 1990s.

The most common approach is the 5-cm rule. Measure 5 centimeters forward from the motor cortex, place the coil there, and call it the dorsolateral prefrontal cortex. It is simple, requires no imaging, and it works well enough that TMS earned FDA clearance. But well enough leaves room to do better.

Brain anatomy varies significantly between individuals. Your dorsolateral prefrontal cortex is not in exactly the same spot as mine, and the specific subregion that connects to mood-regulating circuits shifts by up to two centimeters from person to person. Two centimeters does not sound like much until you consider that the TMS coil’s focal point is roughly the size of a quarter.

Miss the sweet spot and you are stimulating brain tissue next to, but not part of, the circuit you need. The treatment might still work partially. Or it might not work at all. This targeting variability is widely believed to be the main reason TMS response rates have plateaued around 50-60% for the past decade.

Artificial intelligence is finally cracking this problem open.

What You’ll Learn

• Why inconsistent targeting has held TMS outcomes back
• How AI-guided targeting works using neuroimaging and machine learning
• What outcome improvements AI targeting actually delivers
• What imaging costs and where to get it
• The technology landscape and what it means for you right now

How AI-Guided Targeting Works

The basic idea is intuitive, even if the engineering behind it is genuinely complex. You get a brain scan, usually a functional MRI, sometimes combined with structural MRI and diffusion tensor imaging. You feed it to machine learning algorithms trained on thousands of previous scans from people whose TMS outcomes are known.

The AI does two things. First, it maps your individual brain connectivity, pinpointing the exact cortical target with the strongest functional connection to deeper mood-regulating structures like the subgenual anterior cingulate cortex. That is the where to aim problem.

Second, and this is newer, some systems predict how likely you are to respond to TMS at all, based on your brain connectivity patterns and clinical features. That is the should we aim problem. Equally important, but historically ignored.

Several commercial platforms have emerged to make this practical. Companies like Magnus Medical, BrainsWay, and academic spin-offs from Stanford, Harvard, and Emory have built software that takes your neuroimaging data and produces a specific coil placement coordinate, often rendered as a 3D target that clinicians can see during setup.

From your perspective, it is straightforward. You get a brain scan, about 45-60 minutes in the MRI machine, before your TMS course begins. The scan gets uploaded, the software processes it, and your clinician gets a personalized targeting map. Your TMS sessions then use neuronavigation, a GPS-like system that tracks the coil’s position relative to your brain anatomy in real time, to hit that target consistently.

The Outcome Improvements Are Real

This is not theoretical. Multiple clinical studies have compared AI-guided or fMRI-guided TMS targeting to standard anatomical targeting in head-to-head designs.

The consistent finding: a 15-20% improvement in response rates. Studies from Stanford, the Medical University of South Carolina, and several European centers have landed on similar numbers. Going from 50% response to 65-70% response means a meaningful number of people who would have been labeled TMS non-responders under the old approach actually just needed better aim.

The Stanford Neuromodulation Therapy protocol, which combines fMRI targeting with accelerated stimulation, pushed remission rates to 79% in treatment-resistant cases. It is hard to tease apart the targeting contribution from the accelerated dosing contribution. Both likely matter.

Prediction accuracy is getting interesting too. Current AI models can predict TMS response with roughly 75% accuracy before treatment starts, based on baseline brain connectivity patterns and clinical variables. Not perfect, but a lot better than the current standard, which is basically try it and see.

Three out of four times, the algorithm correctly identifies whether you will respond or not. For people predicted to be non-responders, this opens the door to alternative approaches: different coil placements, different stimulation parameters, or entirely different treatments. Rather than spending six weeks on a protocol unlikely to help.

What Imaging Costs and Where to Get It

The added cost of neuroimaging is the main barrier right now. A functional MRI session runs $500-$1,500 depending on your location, the imaging center, and whether your insurance covers it. Some centers bundle the scan into their overall TMS treatment package. Others bill it separately.

Insurance coverage for the neuroimaging piece is inconsistent. The MRI itself is usually covered when ordered with an appropriate diagnostic code. But some insurers question the medical necessity of fMRI specifically for TMS targeting. Prior authorization and a letter of medical necessity from your provider can help. Check our insurance guide for carrier-specific information.

Not every TMS clinic offers AI-guided targeting yet. The ones that do tend to be academic medical centers, larger specialty practices, and clinics that have invested in neuronavigation equipment. You can search our directory to find providers that advertise precision targeting or neuroimaging-guided TMS.

If the clinic nearest to you does not offer fMRI-guided targeting, some providers work with remote imaging analysis services. You get the MRI locally, the data gets sent to a specialized center for processing, and the targeting coordinates come back within a few days.

The Technology Landscape in 2026

Several distinct approaches are competing and, increasingly, combining.

Functional connectivity targeting uses resting-state fMRI to map individual brain networks. This is the approach behind the Stanford SNT protocol and has the strongest clinical evidence. It identifies the best stimulation site based on how your prefrontal cortex connects to subcortical mood circuits.

Structural targeting with AI optimization uses high-resolution structural MRI plus machine learning to predict the best target without requiring functional imaging. Cheaper and faster, though potentially less precise. Some algorithms can generate reasonable targeting coordinates from a standard clinical MRI you might already have on file.

EEG-guided targeting is the budget option. Electroencephalography is cheap, portable, and fast. AI models trained on combined EEG-fMRI datasets can estimate optimal targets from EEG data alone. Not as precise as fMRI-based methods, but meaningfully better than the 5-cm rule and requires no MRI at all.

Real-time adaptive protocols are the frontier. These systems adjust stimulation parameters during treatment based on neural responses measured via EEG or fNIRS. Think of it as closed-loop TMS. The machine monitors your brain’s reaction and tweaks the protocol on the fly. Early results are promising, but this is still largely experimental.

The broader direction is clear. TMS is moving from a one-size-fits-all treatment to a precision medicine approach where the protocol is tailored to your neurobiology.

What This Means for You Right Now

If you are considering TMS or have tried it before without enough results, AI-guided targeting is worth asking about.

If you are a first-time TMS patient and you have access to a clinic that offers neuroimaging-guided targeting, the added cost of the brain scan, $500-$1,500, buys you meaningfully better odds of response. Whether that is worth it depends on your finances and insurance, but the clinical case is clear.

If you tried standard TMS and it did not work, poor targeting is a plausible explanation. Before concluding that TMS does not work for me, consider a course with precision targeting. A real number of standard-TMS non-responders have responded when re-treated with fMRI-guided protocols.

If you are choosing between providers, ask about their targeting method. A clinic using neuronavigation and neuroimaging is working with fundamentally more information than one using the 5-cm rule. Our specialist directory can help you find providers who use advanced targeting approaches.

Five years from now, treating everyone with the same coil placement will likely seem as outdated as prescribing the same antidepressant dose to every person regardless of weight, genetics, or metabolism. The tools for personalization exist today. They are just not standard yet.